» Authors » Erica L Hamilton

Erica L Hamilton

Explore the profile of Erica L Hamilton including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 287
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stranix-Chibanda L, Hamilton E, Ngo J, Jiao Y, Hanscom B, Choudhury R, et al.
Lancet HIV . 2025 Mar; PMID: 40088909
Background: Long-acting formulations of HIV pre-exposure prophylaxis (PrEP) appear particularly well suited to adolescents. We aimed to establish the safety, tolerability, and acceptability of long-acting injectable cabotegravir as PrEP in...
2.
Ondenge K, Guo X, Mbeda C, Schnabel D, Panchia R, Dominguez K, et al.
AIDS Behav . 2024 Nov; 29(3):747-759. PMID: 39607599
Studies among men who have sex with men (MSM) in sub-Saharan Africa (SSA) focus mainly on HIV epidemiology, revealing little about the diversity within this population. We utilized data from...
3.
Sandfort T, Kreniske P, Mbeda C, Reynolds D, Tshabalala G, Madiwati B, et al.
AIDS Behav . 2024 May; 28(7):2361-2377. PMID: 38761334
This study explored interest in injectable PrEP (I-PrEP) and willingness to participate in clinical trials testing new biomedical HIV prevention strategies among men and transfeminine persons who have sex with...
4.
Mbilizi Chimwaza Y, Dadabhai S, Nyondo Mipando A, Mbeda C, Panchia R, Lucas J, et al.
PLOS Glob Public Health . 2023 Mar; 2(12):e0001408. PMID: 36962926
There remains a limited understanding of how men who have sex with men (MSM) and transgender women (TGW) in sub-Saharan Africa (SSA) perceive their risk for HIV and how risk...
5.
Tolley E, Hamilton E, Eley N, Maragh-Bass A, Okumu E, Balan I, et al.
AIDS Behav . 2022 Apr; 26(9):3119-3130. PMID: 35362913
Adherence to care and antiretroviral therapy is challenging, especially for people living with HIV (PLWH) with additional co-occurring risk factors. Case management interventions, including motivational interviewing (MI), show promise to...
6.
Lancaster K, Mollan K, Hanscom B, Shook-Sa B, Ha T, Dumchev K, et al.
Open Forum Infect Dis . 2021 Aug; 8(8):ofab281. PMID: 34458390
Background: People who inject drugs (PWID) living with HIV experience inadequate access to antiretroviral treatment (ART) and medication for opioid use disorders (MOUD). HPTN 074 showed that an integrated intervention...
7.
Sandfort T, Mbilizi Y, Sanders E, Guo X, Cummings V, Hamilton E, et al.
PLoS One . 2021 Feb; 16(2):e0247195. PMID: 33630925
Few studies have assessed HIV incidence in men who have sex with men (MSM) and transgender women (TGW) in sub-Saharan Africa (SSA). We assessed HIV incidence and its correlates among...
8.
Palumbo P, Zhang Y, Clarke W, Breaud A, Sivay M, Cummings V, et al.
Int J Infect Dis . 2021 Jan; 104:465-470. PMID: 33440260
Objectives: HPTN 075 enrolled men who have sex with men (MSM) and transgender women (TGW) in sub-Saharan Africa. Persons in HIV care or on antiretroviral treatment (ART) were not eligible...
9.
Sandfort T, Hamilton E, Marais A, Guo X, Sugarman J, Chen Y, et al.
J Int AIDS Soc . 2020 Oct; 23 Suppl 6:e25600. PMID: 33000911
Introduction: Men who have sex with men (MSM) and transgender women (TGW) in sub-Saharan Africa (SSA) are profoundly affected by HIV with high HIV prevalence and incidence. This population also...
10.
Kiriazova T, Go V, Hershow R, Hamilton E, Sarasvita R, Bui Q, et al.
Harm Reduct J . 2020 Oct; 17(1):69. PMID: 32998731
Background: Opioid agonist treatment (OAT) is an effective method of addiction treatment and HIV prevention. However, globally, people who inject drugs (PWID) have insufficient OAT uptake. To expand OAT access...